Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Luis de la Cruz"'
Autor:
Horacio J. Asbun, Mohammad Abu Hilal, Filipe Kunzler, Domenech Asbun, Jaap Bonjer, Kevin Conlon, Nicolas Demartines, Liane S. Feldman, Salvador Morales-Conde, Andrea Pietrabissa, Aurora D. Pryor, Christopher M. Schlachta, Patricia Sylla, Eduardo M. Targarona, Yolanda Agra, Marc G. Besselink, Mark Callery, Sean P. Cleary, Luis De La Cruz, Philippe Eckert, Chad Evans, Ho-Seong Han, Daniel B. Jones, Tong Joo Gan, Daniel Koch, Keith D. Lillemoe, Davide Lomanto, Jeffrey Marks, Brent Matthews, John Mellinger, William Scott Melvin, Eduardo Moreno-Paquentin, Claudio Navarrete, Timothy M. Pawlik, Patrick Pessaux, Walter Ricciardi, Steven Schwaitzberg, Paresh Shah, Joseph Szokol, Mark Talamini, Ricardo Torres, Alessandro Triboldi, Suthep Udomsawaengsup, Federica Valsecchi, Jean-Nicolas Vauthey, Michael Wallace, Steven D. Wexner, Michael Zinner, Nader Francis
Publikováno v:
Annals of surgery, 274(1), 50-56. Lippincott Williams and Wilkins
ANNALS OF SURGERY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
ANNALS OF SURGERY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Objective: The aim of this work is to formulate recommendations based on global expert consensus to guide the surgical community on the safe resumption of surgical and endoscopic activities. Background: The COVID-19 pandemic has caused marked disrupt
Autor:
Olga Rosa Brito-Zurita, Jaime López-Cervantes, José Luis De La Cruz-Mercado, Ana A. Escárcega-Galaz, Dalia I. Sánchez-Machado, José Manuel Ornelas-Aguirre
Publikováno v:
Saudi Journal of Biological Sciences, Vol 25, Iss 1, Pp 130-135 (2018)
Infections, ulcerations, gangrene and, in severe cases, extremity amputation, are common complications among diabetic subjects. Various biomaterials have been utilized for the treatment of these lesions. Chitosan is an amino sugar with a low risk of
Autor:
Juan Maestre Antequera, Idoia Díaz-Güemes Martín-Portugués, Javier G. Casado, José Luis De la Cruz Vigo, Ana M. Matos Azevedo, Francisco M. Sánchez-Margallo, Laura Hernández Hurtado
Publikováno v:
Obesity Surgery. 26:3001-3006
The objective of the study was to assess Roux-en-Y independent-to-weight metabolic effects on an obese Gottingen minipig.Eleven castrated Göttingen minipigs were enrolled. Minipigs became obese after a 9-month period of experimental diet. The animal
Publikováno v:
Endocrine-Related Cancer. 23:R71-R84
In differentiated thyroid carcinoma refractory to radioactive iodine (CDT-RTI), chemotherapy has been considered for decades to be the only systemic therapy with palliative purpose. Phase II studies assessing the efficacy of different chemotherapy ou
Autor:
Thomas Bachelot, Alberto Ballestrero, Marco Colleoni, José Valero Alvarez, Amer Sami, Celalettin Camci, Rodrigo Lastra del Prado, Luis De La Cruz Merino, Antonio Bernardo, Peter Barrett-Lee, Yolanda Fernández Pérez, Vladimir Semiglazov, Thierry Petit, Mette Holck Nielsen, C. Langridge, Guillermo López Vivanco, Nik Hauser, Ignacio Porras Quintela, José Manuel Pérez García, Anna-Karin Wennstig, Victoria Dvornichenko, Erik Jakobsen, Guzel Mukhametshina, Heiko Graf, V. Jenkins, Mireille Mousseau, Alfonso Sanchez Muñoz, Pehr Lind, Irina Bulavina, Alexey Manikhas, Bengt Norberg, Xavier Pivot, Per Edlund, Sandeep Sehdev, Valerie Jenkins, Santos Enrech Frances, Nadia Califaretti, V. Müller, G. Curigliano, Duncan Wheatley, Stephen L. Chan, Enrique Espinosa Arranz, S. Osborne, Soeren Linnet, Nana Scotto, J. Gligorov, Volkmar Müller, Tjoung-Won Park-Simon, Karen McAdam, Ann Knoop, Giuseppe Curigliano, X. Pivot, Justine Kilkerr, Georg Heinrich, L. Fallowfield, Francisco Carabantes Ocon, Christopher Wolf, Robert El-Maraghi, Hugues Bourgeois, Christelle Levy, Luca Gianni, Russell Burcombe, Vadim Shirinkin, Huseyin Abali, Etienne Brain, Christoph Tausch, Lidia Perlova-Griff, Claudia Plesse Lefeuvre, Joseph Gligorov, Mikhail Lichinitser, Friedrich Overkamp, S. Verma, Kathryn Monson, Angela Stefania Ribecco, Doris Augustin, Lesley Fallowfield, Saad Tahir, Javier Cassinello Espinosa, Marcus Schmidt, Jacek Jassem, Laurent Zelek, Ruchan Uslu, Richard Simcock, Sherko Kuemmel, Javier Salvador Bofill, A. Knoop, Hervé Bonnefoi, Fikret Arpaci, Silvana Spadafora, Sunil Verma, Hendrik Kroening, Elżbieta Brewczynska
Publikováno v:
Annals of Oncology. 25:1979-1987
Patients with HER2-positive early breast cancer (EBC) preferred subcutaneous (s.c.) trastuzumab, delivered via single-use injection device (SID), over the intravenous (i.v.) formulation (Cohort 1 of the PrefHer study: NCT01401166). Here, we report pa
Autor:
Ivan Marquez-Rodas, Purificación Martínez de Prado, Elia Samaniego, Lorenzo Alonso, Rafael López Castro, María Quindós, Luis de la Cruz-Merino, Enrique Espinosa, Guillermo Lopez-Vivanco, Rafael López, Pablo Cerezuela, Vicente Guillem, Kendall Stevinson, Virtudes Soriano, Salvador Martín-Algarra, Alfonso Berrocal, Ainara Soria, Patricia del Barrio, Rodrigo Díaz-Beveridge, Teresa Puertolas, M.V. Tornamira, Josep Malvehy, Ana Isabel Ballesteros, Isabel Palacio
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Melanoma Research
Consejería de Sanidad de la Comunidad de Madrid
Melanoma Research
Adjuvant interferon-α2b (IFN-α2b) has been studied extensively in clinical trials, but there have been few studies of real-world use. The aim of this study is to describe the IFN-α2b real-world patterns in patients with high-risk melanoma in Spain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f70d5407059dccf0f0f1f74449ff9e6
https://hdl.handle.net/10668/9903
https://hdl.handle.net/10668/9903
Autor:
Antoni Ribas, Brigitte Dréno, Anna Maria Di Giacomo, Victoria Atkinson, Mario Mandalà, Claus Garbe, Luc Thomas, Grant A. McArthur, James Larkin, Luis de la Cruz-Merino, Paolo A. Ascierto, Daniil Stroyakovskiy, Isabelle Rooney, Jessie J. Hsu, Caroline Dutriaux, Lev V. Demidov, Matthew Wongchenko, Daniel O. Koralek, Ilsung Chang, G. Liszkay, Yibing Yan
The combination of cobimetinib with vemurafenib improves progression-free survival compared with placebo and vemurafenib in previously untreated patients with BRAF(V600)-mutant advanced melanoma, as previously reported in the coBRIM study. In this Ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace978176cf5d18d1e720f399aec8567
https://hdl.handle.net/11365/1233346
https://hdl.handle.net/11365/1233346
Autor:
Roman Villegas-Portero, Lara Ferrándiz, Luis de la Cruz-Merino, Adoracion Nieto-Garcia, David Moreno-Ramírez
Publikováno v:
The Oncologist. 15:416-427
Learning Objectives After completing this course, the reader will be able to: Compare the response rate of ILP with melphalan and TNF to the response rate of ILP with single-agent melphalan in patients with unresectable locally advanced melanoma of t
Autor:
Stephen P. Hack, James Larkin, Luis de la Cruz-Merino, Grant A. McArthur, Luc Thomas, Nicholas Choong, Claus Garbe, Gabriella Liszkay, Victoria Atkinson, Daniil Stroyakovskiy, Ilsung Chang, Lev V. Demidov, Mario Mandalà, Caroline Dutriaux, Brigitte Dréno, Antoni Ribas, Mika A. Sovak, Paolo A. Ascierto, Michele Maio
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; BACKGROUND The combined inhibition of BRAF and MEK is hypothesized to improve clinical outcomes in patients with melanoma by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::058bae456f14e0981fcd75b5620ef91e
https://hdl.handle.net/10668/2159
https://hdl.handle.net/10668/2159
Autor:
José Luis De la Cruz-Vigo, José María Canga-Presa, José Ignacio Martínez-Pueyo, Felipe de la Cruz Vigo, Pilar Sanz de la Morena
Publikováno v:
Cirugía Española. 75:292-298